§ Funding Round
LYNK Pharmaceuticals raised $28.1M Series C venture round.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$122.2M
Top Valuation
-
LYNK Pharmaceuticals raised $28.1M in a Series C round.
The round was announced on 06/01/23.
